APA (7th ed.) Citation

WH, T., CH, H., HH, C., MC, W., HH, L., & SM, H. (2020). Comparisons of Clinical Outcomes in Women with Advanced Ovarian Cancer Treated with Frontline Intraperitoneal versus Dose-Dense Platinum/Paclitaxel Chemotherapy without Bevacizumab. International journal of environmental research and public health, 17(10), . https://doi.org/10.3390/ijerph17103603

Chicago Style (17th ed.) Citation

WH, Ting, Hsiao CH, Chen HH, Wei MC, Lin HH, and Hsiao SM. "Comparisons of Clinical Outcomes in Women with Advanced Ovarian Cancer Treated with Frontline Intraperitoneal Versus Dose-Dense Platinum/Paclitaxel Chemotherapy Without Bevacizumab." International Journal of Environmental Research and Public Health 17, no. 10 (2020). https://doi.org/10.3390/ijerph17103603.

MLA (9th ed.) Citation

WH, Ting, et al. "Comparisons of Clinical Outcomes in Women with Advanced Ovarian Cancer Treated with Frontline Intraperitoneal Versus Dose-Dense Platinum/Paclitaxel Chemotherapy Without Bevacizumab." International Journal of Environmental Research and Public Health, vol. 17, no. 10, 2020, https://doi.org/10.3390/ijerph17103603.